Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iHuman (IH) Current Assets (2020 - 2025)

iHuman has reported Current Assets over the past 6 years, most recently at $183.1 million for Q4 2025.

  • Quarterly Current Assets fell 1.56% to $183.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $183.1 million through Dec 2025, down 1.56% year-over-year, with the annual reading at $185.7 million for FY2025, 1.45% up from the prior year.
  • Current Assets was $183.1 million for Q4 2025 at iHuman, down from $186.0 million in the prior quarter.
  • Over five years, Current Assets peaked at $192.0 million in Q4 2023 and troughed at $158.8 million in Q4 2021.
  • The 5-year median for Current Assets is $183.1 million (2025), against an average of $179.2 million.
  • Biggest five-year swings in Current Assets: rose 11.02% in 2022 and later decreased 3.14% in 2024.
  • Tracing IH's Current Assets over 5 years: stood at $158.8 million in 2021, then increased by 11.02% to $176.3 million in 2022, then grew by 8.91% to $192.0 million in 2023, then dropped by 3.14% to $186.0 million in 2024, then decreased by 1.56% to $183.1 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $183.1 million, $186.0 million, and $192.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.